XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
1.165
-0.075 (-6.05%)
At close: Apr 1, 2025, 4:00 PM
1.242
+0.077 (6.57%)
After-hours: Apr 1, 2025, 4:26 PM EDT
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of $10.89 million as of April 1, 2025. Its market cap has increased by 110.68% in one year.
Market Cap
10.89M
Enterprise Value
9.17M
1-Year Change
110.68%
Ranking
Category
Stock Price
$1.17
Market Cap Chart
Since August 31, 2005, XTL Biopharmaceuticals's market cap has decreased from $179.98M to $10.89M, a decrease of -93.95%. That is a compound annual growth rate of -13.34%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.66B |
| UnitedHealth Group | 479.08B |
| Johnson & Johnson | 399.65B |
| AbbVie | 370.64B |
| Novo Nordisk | 302.16B |
| Abbott Laboratories | 230.06B |
| Merck & Co. | 226.74B |
| AstraZeneca | 225.46B |